Common Shares Outstanding: The number of class A shares currently held by investors.
Anavex Life Sciences Corp. (AVXL) had Common Shares Outstanding of 85.33M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-11.20M |
|
-- |
|
-- |
|
$12.51M |
|
$-12.51M |
|
$1.32M |
|
$-11.20M |
|
$-11.20M |
|
$-11.20M |
|
$-11.20M |
|
$-11.20M |
|
$-11.20M |
|
$-12.51M |
|
$-12.51M |
|
85.07M |
|
85.07M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$117.14M |
|
-- |
|
-- |
|
$117.14M |
|
$17.38M |
|
-- |
|
-- |
|
$17.38M |
|
$99.76M |
|
$99.76M |
|
$99.76M |
|
|
Common Shares Outstanding |
85.33M |
| Cash Flow Statement Financials | |
$-17.98M |
|
-- |
|
$1.56M |
|
$132.19M |
|
$115.77M |
|
$-16.42M |
|
$3.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.74 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-17.98M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.22% |
|
-11.22% |
|
-9.56% |
|
-11.22% |
|
$1.17 |
|
$-0.21 |
|
$-0.21 |
|